KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Other financing activities (2016 - 2019)

Historic Other financing activities for BeOne Medicines (ONC) over the last 3 years, with Q2 2019 value amounting to $4.0 million.

  • BeOne Medicines' Other financing activities changed N/A to $4.0 million in Q2 2019 from the same period last year, while for Sep 2020 it was $4.0 million, marking a year-over-year increase of 1154.49%. This contributed to the annual value of $3.0 million for FY2024, which is N/A changed from last year.
  • Per BeOne Medicines' latest filing, its Other financing activities stood at $4.0 million for Q2 2019.
  • Over the past 5 years, BeOne Medicines' Other financing activities peaked at $4.0 million during Q2 2019, and registered a low of -$414000.0 during Q4 2018.
  • Its 3-year average for Other financing activities is $1.2 million, with a median of $740000.0 in 2016.